Azelnidipine, but not amlodipine, reduces urinary albumin excretion and carotid atherosclerosis in subjects with type 2 diabetes: blood pressure control with olmesartan and azelnidipine in Type 2 diabetes (BOAT2 study)

To evaluate the efficacy of azelnidipine and amlodipine on diabetic nephropathy and atherosclerosis, we designed a prospective and randomized controlled clinical study in type 2 diabetic patients with stable glycemic control with fixed dose of anti-diabetic medication. Although there was no differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Tawaramoto, Kazuhito, Kaneto, Hideaki, Hashiramoto, Mitsuru, Kawasaki, Fumiko, Tatsumi, Fuminori, Shimoda, Masashi, Kamei, Shinji, Matsuki, Michihiro, Mune, Tomoatsu, Kaku, Kohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574138/
https://www.ncbi.nlm.nih.gov/pubmed/26388951
http://dx.doi.org/10.1186/s13098-015-0073-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574138/
https://www.ncbi.nlm.nih.gov/pubmed/26388951
http://dx.doi.org/10.1186/s13098-015-0073-9

Ejemplares similares